Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CELive EventsScientific InterchangesState of the Science SummitNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Watch
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Fabien Maldonado, MD, MSc

Advertisement

Articles by Fabien Maldonado, MD, MSc

Lung Cancer Screening   | Image credit: © stock.adobe.com

Redefining Early Lung Cancer Screening Through Imaging and Biomarker Advances

ByFabien Maldonado, MD, MSc,Eric L. Grogan, MD, MPH,Stephen Deppen, PhD
January 19th 2026

Experts discuss the latest advancements in early lung cancer screening, including biomarkers and technologies that enhance detection and patient outcomes.

Advertisement

Latest Updated Articles

  • Lung Cancer Screening   | Image credit: © stock.adobe.com
    Redefining Early Lung Cancer Screening Through Imaging and Biomarker Advances

    January 19th 2026



Advertisement
Advertisement

Trending on OncLive

1

Sintilimab Receives Positive CHMP Opinion for First-Line Nonsquamous NSCLC

2

Galinpepimut-S Improves OS in AML in Second or Later Remission

3

FDA Removes Limitations of Use for Liso-Cel in Primary Central Nervous System Lymphoma

4

ESMO 2026 Data Highlight ADC Activity in Brain Metastases and TNBC

5

Updated KANDLELIT-001 Data Show Durable Responses With Frontline Calderasib Plus Pembrolizumab in KRAS G12C–Mutated NSCLC

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us